(Q50160858)

English

Improved optimal cytoreduction rates for stages IIIC and IV epithelial ovarian, fallopian tube, and primary peritoneal cancer: a change in surgical approach.

scientific article published in September 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 February 2018

http://europepmc.org/abstract/MED/15350354

Improved optimal cytoreduction rates for stages IIIC and IV epithelial ovarian, fallopian tube, and primary peritoneal cancer: a change in surgical approach. (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 February 2018

http://europepmc.org/abstract/MED/15350354

1 reference

based on heuristic

inferred from title

1

object named as

Dennis S Chi

1 reference

Europe PubMed Central

PubMed publication ID

26 February 2018

http://europepmc.org/abstract/MED/15350354

Richard R Barakat

10

object named as

Richard R Barakat

1 reference

Europe PubMed Central

PubMed publication ID

26 February 2018

http://europepmc.org/abstract/MED/15350354

Nadeem R. Abu-Rustum

9

object named as

Nadeem R Abu-Rustum

1 reference

Europe PubMed Central

PubMed publication ID

26 February 2018

http://europepmc.org/abstract/MED/15350354

Ronald P DeMatteo

7

object named as

Ronald DeMatteo

1 reference

Europe PubMed Central

PubMed publication ID

26 February 2018

http://europepmc.org/abstract/MED/15350354

Douglas A Levine

3

object named as

Douglas A Levine

1 reference

Europe PubMed Central

PubMed publication ID

26 February 2018

http://europepmc.org/abstract/MED/15350354

William R Jarnagin

6

object named as

William R Jarnagin

1 reference

Europe PubMed Central

PubMed publication ID

26 February 2018

http://europepmc.org/abstract/MED/15350354

Elizabeth A Poynor

8

object named as

Elizabeth A Poynor

1 reference

Europe PubMed Central

PubMed publication ID

26 February 2018

http://europepmc.org/abstract/MED/15350354

Corinna C Franklin

2

object named as

Corinna C Franklin

1 reference

Europe PubMed Central

PubMed publication ID

26 February 2018

http://europepmc.org/abstract/MED/15350354

Paul J. Sabbatini

5

object named as

Paul Sabbatini

1 reference

Europe PubMed Central

PubMed publication ID

26 February 2018

http://europepmc.org/abstract/MED/15350354

author name string

Faina Akselrod

4

1 reference

Europe PubMed Central

PubMed publication ID

26 February 2018

http://europepmc.org/abstract/MED/15350354

language of work or name

0 references

publication date

1 September 2004

1 reference

Europe PubMed Central

PubMed publication ID

26 February 2018

http://europepmc.org/abstract/MED/15350354

Gynecologic Oncology

1 reference

Europe PubMed Central

PubMed publication ID

26 February 2018

http://europepmc.org/abstract/MED/15350354

94

1 reference

Europe PubMed Central

PubMed publication ID

26 February 2018

http://europepmc.org/abstract/MED/15350354

3

1 reference

Europe PubMed Central

PubMed publication ID

26 February 2018

http://europepmc.org/abstract/MED/15350354

650-654

1 reference

Europe PubMed Central

PubMed publication ID

26 February 2018

http://europepmc.org/abstract/MED/15350354

Cancer statistics, 2003.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.01.029

7 January 2021

Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.01.029

7 January 2021

The cavitational ultrasonic surgical aspirator for cytoreduction in advanced ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.01.029

7 January 2021

Complete cytoreductive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.01.029

7 January 2021

Prognostic factors in advanced ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.01.029

7 January 2021

Stage IV ovarian cancer: impact of surgical debulking

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.01.029

7 January 2021

The ability of preoperative serum CA-125 to predict optimal primary tumor cytoreduction in stage III epithelial ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.01.029

7 January 2021

Identification of prognostic factors in advanced epithelial ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.01.029

7 January 2021

Quality of complication reporting in the surgical literature

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.01.029

7 January 2021

The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.01.029

7 January 2021

Epithelial ovarian carcinoma: principles of primary surgery

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.01.029

7 January 2021

Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.01.029

7 January 2021

Relative influences of tumor volume before surgery and the cytoreductive outcome on survival for patients with advanced ovarian cancer: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.01.029

7 January 2021

What are the current surgical objectives, strategies, and technical capabilities of gynecologic oncologists treating advanced epithelial ovarian cancer?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.01.029

7 January 2021

Identifiers

10.1016/J.YGYNO.2004.01.029

1 reference

Europe PubMed Central

PubMed publication ID

26 February 2018

http://europepmc.org/abstract/MED/15350354

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 February 2018

http://europepmc.org/abstract/MED/15350354

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50160858&oldid=1752932450"